{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:34:12Z","timestamp":1795196052637,"version":"4.10.3"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>To derive systematic-review informed, modified Delphi consensus regarding the medications used for anticoagulation for pediatric extracorporeal membrane oxygenation (ECMO) for the Pediatric ECMO Anticoagulation CollaborativE (PEACE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>A structured literature search was performed using PubMed, EMBASE, and Cochrane Library (CENTRAL) databases from January 1988 to May 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY SELECTION:<\/jats:title>\n                    <jats:p>Included studies assessed anticoagulation used in pediatric ECMO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA EXTRACTION:<\/jats:title>\n                    <jats:p>Two authors reviewed all citations independently, with a third reviewer adjudicating any conflicts. Eighteen references were used for data extraction as well as for creation of recommendations. Evidence tables were constructed using a standardized data extraction form.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SYNTHESIS:<\/jats:title>\n                    <jats:p>Risk of bias was assessed using the Quality in Prognosis Studies tool. The evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation system. Forty-eight experts met over 2 years to develop evidence-informed recommendations and, when evidence was lacking, expert-based consensus statements, or good practice statements for anticoagulation during pediatric ECMO. A web-based modified Delphi process was used to build consensus via the Research and Development\/University of California Appropriateness Method. Consensus was based on a modified Delphi process with agreement defined as greater than 80%. Two recommendations, two consensus statements, and one good practice statement were developed, and, in all, agreement greater than 80% was reached.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>There is insufficient evidence to formulate optimal anticoagulation therapy during pediatric ECMO. Additional high-quality research is needed to inform evidence-based practice for anticoagulation during pediatric ECMO.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003495","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T10:12:12Z","timestamp":1720001532000},"page":"e7-e13","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Anticoagulant Medications: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference"],"prefix":"10.1097","volume":"25","author":[{"given":"Katherine","family":"Cashen","sequence":"first","affiliation":[{"name":"Division of Critical Care Medicine, Department of Pediatrics, Duke University and Duke University Health System, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Saini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Pediatric Critical Care Medicine, Texas Children\u2019s Hospital, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo R.","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Hospital for Sick Children, Dalla Lana School of Public Health, University of Toronto, Toronto, ON."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Le","sequence":"additional","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Monagle","sequence":"additional","affiliation":[{"name":"University of Melbourne, Melbourne, VIC, Australia."},{"name":"Kids Cancer Centre Sydney Children\u2019s Hospital, Melbourne, VIC, Australia."},{"name":"Murdoch Children\u2019s Research Institute, Melbourne, VIC, Australia."},{"name":"Royal Children\u2019s Hospital, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie M.","family":"Moynihan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Boston Children\u2019s Hospital, Boston, MA."},{"name":"Department of Pediatrics, Harvard Medical School, Boston, MA."},{"name":"Westmead Children\u2019s Hospital, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Ryerson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stollery Children\u2019s Hospital, University of Alberta, Edmonton, AB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Gehred","sequence":"additional","affiliation":[{"name":"Grant Morrow III MD Medical Library, Nationwide Children\u2019s Hospital Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Lyman","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Pediatrics, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Muszynski","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Pediatrics, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peta M.A.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Boston Children\u2019s Hospital, Boston, MA."},{"name":"Department of Pediatrics, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi J","family":"Dalton","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, INOVA Fairfax Medical Center, Falls Church, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Pediatric Extracorporeal Membrane Oxygenation (ECMO) Anticoagulation CollaborativE (PEACE), in collaboration with the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, the Pediatric Critical Care Blood Research Network (BloodNet), and the Pediatric ECMO subgroup of PALISI and the Extracorporeal Life Support Organization (PediECMO)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1164\/rccm.201609-1945OC","article-title":"Factors associated with bleeding and thrombosis in children receiving extracorporeal membrane oxygenation.","volume":"196","author":"Dalton","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PCC.0000000000002073","article-title":"Mortality and factors associated with hemorrhage during pediatric extracorporeal membrane oxygenation.","volume":"21","author":"O\u2019Halloran","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1097\/CCM.0000000000003086","article-title":"RBC transfusion practice in pediatric extracorporeal membrane oxygenation support.","volume":"46","author":"Muszynski","year":"2018","journal-title":"Crit Care Med"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/PCC.0b013e31827127e4","article-title":"Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: An international survey.","volume":"14","author":"Bembea","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/PCC.0000000000002696","article-title":"Anticoagulation and transfusion management during neonatal and pediatric extracorporeal membrane oxygenation: A survey of medical directors in the United States.","volume":"22","author":"Ozment","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.athoracsur.2006.09.054","article-title":"Anticoagulation and pediatric extracorporeal membrane oxygenation: Impact of activated clotting time and heparin dose on survival.","volume":"83","author":"Baird","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0267659117720494","article-title":"Coagulation monitoring correlation with heparin dose in pediatric extracorporeal life support.","volume":"32","author":"Moynihan","year":"2017","journal-title":"Perfusion"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI114723","article-title":"Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.","volume":"86","author":"Weitz","year":"1990","journal-title":"J Clin Invest"},{"key":"R10-20250502","first-page":"408","article-title":"Bivalirudin as an alternative to heparin for anticoagulation in infants and children.","volume":"20","author":"Buck","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/PCC.0000000000003480","article-title":"Pediatric Extracorporeal Membrane Oxygenation (ECMO) Anticoagulation CollaborativE (PEACE), in collaboration with the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, the Pediatric Critical Care Blood Research Network (BloodNet), and the Pediatric ECMO subgroup of PALISI and the Extracorporeal Life Support Organization (PediECMO): Executive summary: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference.","volume":"25","author":"Alexander","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors.","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence.","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jclinepi.2015.11.017","article-title":"A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach.","volume":"72","author":"Neumann","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines.","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 1: Introduction.","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13012-016-0462-y","article-title":"The GRADE evidence-to-decision framework: A report of its testing and application in 15 international guideline panels.","volume":"11","author":"Neumann","year":"2016","journal-title":"Implement Sci"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies.","volume":"67","author":"Diamond","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/155698451000500608","article-title":"Thromboembolic events in patients on extracorporeal membrane oxygenation without anticoagulation.","volume":"5","author":"Lamarche","year":"2010","journal-title":"Innovations (Phila)"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MAT.0000000000000442","article-title":"Is stopping heparin safe in patients on extracorporeal membrane oxygenation treatment?","volume":"63","author":"Chung","year":"2017","journal-title":"ASAIO J"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.21037\/jtd.2020.04.54","article-title":"Extracorporeal membrane oxygenation without systemic anticoagulation: A case-series in challenging conditions.","volume":"12","author":"Fina","year":"2020","journal-title":"J Thorac Dis"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.athoracsur.2019.08.040","article-title":"Venoarterial-extracorporeal membrane oxygenation without routine systemic anticoagulation decreases adverse events.","volume":"109","author":"Wood","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MAT.0000000000001230","article-title":"Thrombosis and bleeding in extracorporeal membrane oxygenation (ECMO) without anticoagulation: A systematic review.","volume":"67","author":"Olson","year":"2021","journal-title":"ASAIO J"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0022-3468(91)90510-Z","article-title":"ECMO without heparin: Laboratory and clinical experience.","volume":"26","author":"Whittlesey","year":"1991","journal-title":"J Pediatr Surg"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/MAT.0000000000001062","article-title":"Bivalirudin experience in a heterogeneous ventricular assist device population.","volume":"66","author":"Bates","year":"2020","journal-title":"ASAIO J"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/MAT.0000000000001093","article-title":"Utilization and outcomes of children treated with direct thrombin inhibitors on paracorporeal ventricular assist device support.","volume":"66","author":"VanderPluym","year":"2020","journal-title":"ASAIO J"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/PCC.0000000000002527","article-title":"Prospective exploratory experience with bivalirudin anticoagulation in pediatric extracorporeal membrane oxygenation.","volume":"21","author":"Ryerson","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1097\/PCC.0b013e31827200b6","article-title":"Bivalirudin in pediatric patients maintained on extracorporeal life support.","volume":"14","author":"Nagle","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MAT.0000000000001291","article-title":"Bivalirudin may reduce the need for red blood cell transfusion in pediatric cardiac patients on extracorporeal membrane oxygenation.","volume":"67","author":"Machado","year":"2021","journal-title":"ASAIO J"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/aor.13758","article-title":"Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high-volume center.","volume":"45","author":"Schill","year":"2021","journal-title":"Artif Organs"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/CCM.0000000000005033","article-title":"Comparison of bivalirudin versus heparin for maintenance systemic anticoagulation during adult and pediatric extracorporeal membrane oxygenation.","volume":"49","author":"Seelhammer","year":"2021","journal-title":"Crit Care Med"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/PCC.0000000000002384","article-title":"Evaluation of bivalirudin as an alternative to heparin for systemic anticoagulation in pediatric extracorporeal membrane oxygenation.","volume":"21","author":"Hamzah","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1060028020937819","article-title":"Description of bivalirudin use for anticoagulation in pediatric patients on mechanical circulatory support.","volume":"55","author":"Campbell","year":"2021","journal-title":"Ann Pharmacother"},{"key":"R37-20250502","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.thromres.2020.07.043","article-title":"A perioperative bivalirudin anticoagulation protocol for neonates with congenital diaphragmatic hernia on extracorporeal membrane oxygenation.","volume":"193","author":"Snyder","year":"2020","journal-title":"Thromb Res"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/cc11314","article-title":"Bivalirudin and post-cardiotomy ECMO: A word of caution.","volume":"16","author":"Ranucci","year":"2012","journal-title":"Crit Care"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/jth.12153","article-title":"Systematic review on heparin-induced thrombocytopenia in children: A call to action.","volume":"11","author":"Avila","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R40-20250502","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpeds.2020.06.081","article-title":"Heparin-induced thrombocytopenia in a pediatric population: Implications for clinical probability scores and testing.","volume":"226","author":"Avila","year":"2020","journal-title":"J Pediatr"},{"key":"R41-20250502","doi-asserted-by":"crossref","first-page":"1076029620962857","DOI":"10.1177\/1076029620962857","article-title":"Prediction of heparin induced thrombocytopenia (HIT) using a combination of 4Ts score and screening immune assays.","volume":"26","author":"Thawani","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"R42-20250502","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3468(97)90701-6","article-title":"Application of a new anticoagulant (Nafamostat Mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation\u2014a preliminary report.","volume":"32","author":"Nagaya","year":"1997","journal-title":"J Pediatr Surg"},{"key":"R43-20250502","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa1014164","article-title":"Prospective trial of a pediatric ventricular assist device.","volume":"367","author":"Fraser","year":"2012","journal-title":"N Engl J Med"},{"key":"R44-20250502","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.healun.2017.05.020","article-title":"Impact of a modified anti-thrombotic guideline on stroke in children supported with a pediatric ventricular assist device.","volume":"36","author":"Rosenthal","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R45-20250502","first-page":"8824531","article-title":"Utilization of thromboelastogram and inflammatory markers in the management of hypercoagulable state in patients with COVID-19 requiring ECMO support.","volume":"2021","author":"Smolarz","year":"2021","journal-title":"Case Rep Crit Care"},{"key":"R46-20250502","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/02676591211020904","article-title":"Extracorporeal membrane oxygenation for multisystem inflammatory syndrome in children.","volume":"37","author":"Schneider","year":"2022","journal-title":"Perfusion"},{"key":"R47-20250502","doi-asserted-by":"crossref","first-page":"e0159973","DOI":"10.1371\/journal.pone.0159973","article-title":"Dual antiplatelet therapy (DAPT) versus no antiplatelet therapy and incidence of major bleeding in patients on venoarterial extracorporeal membrane oxygenation.","volume":"11","author":"Staudacher","year":"2016","journal-title":"PLoS One"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T14:02:47Z","timestamp":1746194567000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003495","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}